|
MAX expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
8.284800E-03 |
| Normal-vs-Stage3 |
8.74390000404901E-08 |
| Normal-vs-Stage4 |
1.11579999995115E-06 |
| Stage1-vs-Stage2 |
1.208010E-02 |
| Stage1-vs-Stage3 |
1.091010E-01 |
| Stage1-vs-Stage4 |
3.340400E-01 |
| Stage2-vs-Stage3 |
2.479000E-01 |
| Stage2-vs-Stage4 |
1.788970E-01 |
| Stage3-vs-Stage4 |
7.196000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
2.48489999999935E-05 |
| Normal-vs-Asian |
5.195900E-03 |
| Caucasian-vs-AfricanAmerican |
8.569000E-01 |
| Caucasian-vs-Asian |
1.292310E-02 |
| AfricanAmerican-vs-Asian |
1.600010E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94320123828129E-13 |
| Normal-vs-Female |
6.66133814775094E-16 |
| Male-vs-Female |
1.303370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.275400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(61-80Yrs) |
1.84939841219034E-11 |
| Normal-vs-Age(81-100Yrs) |
1.720200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.018600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.405800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.279400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.109800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.956600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.26230003805983E-09 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.09800002423555E-09 |
| Normal-vs-Grade 4 |
9.56450000000331E-05 |
| Grade 1-vs-Grade 2 |
5.933600E-01 |
| Grade 1-vs-Grade 3 |
1.412550E-01 |
| Grade 1-vs-Grade 4 |
1.099050E-01 |
| Grade 2-vs-Grade 3 |
7.838500E-03 |
| Grade 2-vs-Grade 4 |
1.023590E-01 |
| Grade 3-vs-Grade 4 |
8.333400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
5.39340000438315E-08 |
| ccA subtype-vs-ccB subtype |
1.583890E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36446409726432E-13 |
| Normal-vs-N1 |
1.718990E-01 |
| N0-vs-N1 |
3.495400E-01 |
|
|
